|
2025-06-04 |
2025-06-02 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
24,000
-6.6%
11.00
USD 264,000
|
24,000
-6.6%
|
11.00
|
USD 264,000
|
|
|
2025-04-23 |
2025-04-21 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.1%
9.00
USD 36,000
|
4,000
-1.1%
|
9.00
|
USD 36,000
|
|
|
2025-01-23 |
2025-01-21 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.3%
9.00
USD 36,000
|
4,000
-1.3%
|
9.00
|
USD 36,000
|
|
|
2024-11-13 |
2024-11-11 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.2%
9.00
USD 36,000
|
4,000
-1.2%
|
9.00
|
USD 36,000
|
|
|
2024-08-09 |
2024-08-07 |
B
Purchase
|
Samaha Eli
Large shareholder
|
999,800
+11.7%
7.80
USD 7,798,440
|
999,800
+11.7%
|
7.80
|
USD 7,798,440
|
|
|
2024-07-12 |
2024-07-10 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.2%
9.00
USD 36,000
|
4,000
-1.2%
|
9.00
|
USD 36,000
|
|
|
2024-05-03 |
2024-05-01 |
B
Purchase
|
Samaha Eli
Large shareholder
|
499,324
+6.2%
8.75
USD 4,369,085
|
499,324
+6.2%
|
8.75
|
USD 4,369,085
|
|
|
2024-05-03 |
2024-05-01 |
B
Purchase
|
Samaha Eli
Large shareholder
|
999,800
+14.3%
8.75
USD 8,748,250
|
999,800
+14.3%
|
8.75
|
USD 8,748,250
|
|
|
2024-02-22 |
2024-02-22 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,254
-0.4%
8.71
USD 10,922
|
1,254
-0.4%
|
8.71
|
USD 10,922
|
|
|
2023-11-22 |
2023-11-21 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,378
-0.4%
10.29
USD 14,180
|
1,378
-0.4%
|
10.29
|
USD 14,180
|
|
|
2023-11-16 |
2023-11-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
10.22
USD 25,366
|
2,482
-0.7%
|
10.22
|
USD 25,366
|
|
|
2023-10-18 |
2023-10-16 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
9.03
USD 22,412
|
2,482
-0.7%
|
9.03
|
USD 22,412
|
|
|
2023-09-18 |
2023-09-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
9.89
USD 24,547
|
2,482
-0.7%
|
9.89
|
USD 24,547
|
|
|
2023-08-24 |
2023-08-22 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,807
-0.5%
9.47
USD 17,112
|
1,807
-0.5%
|
9.47
|
USD 17,112
|
|
|
2023-08-15 |
2023-08-11 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
9.99
USD 23,197
|
2,322
-0.7%
|
9.99
|
USD 23,197
|
|
|
2023-07-18 |
2023-07-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
9.84
USD 22,848
|
2,322
-0.7%
|
9.84
|
USD 22,848
|
|
|
2023-06-16 |
2023-06-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
10.69
USD 24,822
|
2,322
-0.7%
|
10.69
|
USD 24,822
|
|
|
2023-06-12 |
2023-06-08 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,790
-0.5%
11.13
USD 19,923
|
1,790
-0.5%
|
11.13
|
USD 19,923
|
|
|
2023-05-17 |
2023-05-15 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.6%
11.26
USD 26,146
|
2,322
-0.6%
|
11.26
|
USD 26,146
|
|
|
2023-04-18 |
2023-04-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,323
-0.6%
11.88
USD 27,597
|
2,323
-0.6%
|
11.88
|
USD 27,597
|
|
